Nervgen Pharma NGEN
NASDAQ NGEN
$1.50 -0.04 (-2.60%)
At close: Oct 21, 2026 · 4:00 PM EDT

Nervgen Pharma (NGEN) Common Equity (2024 - 2026)

Updated

Nervgen Pharma (NGEN) reported Common Equity of $12.49 million for the quarter ended Jun 30, 2026, up 209.1% from the prior quarter.

Analysis

Nervgen Pharma (NGEN) Common Equity (2024 - 2026) Analysis & Trends

As of Dec 31, 2025, Nervgen Pharma posted Common Equity of $2.49 million, up 32.2% from the prior year.

  • By year, Common Equity came in at $1.88 million in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 33.88 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 84.97 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -5.94 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 41.98 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 41.95 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 50.37 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 11.69 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 11.83 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 85.49 Bn
10 Nervgen Pharma 108.50 Mn 7.38 Mn - 12.16 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.16 Mn
Mar 31, 2026 3.98 Mn
Dec 31, 2025 2.54 Mn
Dec 31, 2024 1.80 Mn
API Access

Nervgen Pharma Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=NGEN&period=max&api_key=YOUR_API_KEY